Fundraising FoxBrightEdge — 2024 Investments
1 investments dated 2024 · listed companies and verified rows first · show all
Nusanonusano.cominOct 2024
Nusano produces medical radioisotopes for use in theranostic compounds and cancer treatment applications.
BiotechDeep TechHealthtechMedical DevicesWest Valley City, US
Howard C. Lewin(Co-founder & Chief Product Development Officer)inGlenn B. Rosenthal(Co-founder & Chief Technology Officer)in
Co-investorsWasatch Equity PartnersSection 32S32
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.